Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NY › Glens Falls › NPI 1871606764
Agency

Glens Falls Hospital INC

Glens Falls Hospital INC was paid $48.96M by Medicaid between Jan 2018 and Dec 2024, across 485 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 8.3% of everything it billed.

33Billing provider infoGLENS FALLS HOSPITAL INC
GLENS FALLS, NY 12801
33aNPI1871606764assigned 08/16/2006
33bProvider typeEarly Intervention Provider Agency
28Total paid$48.96M
24GClaims1,194,724
24DCodes billed485
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Early Intervention Provider Agency providers in New York

Rank by total paid#5 of 257
Median peer was paid$416K
This provider vs. median118×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M$1.5M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20188,331$384K
201980,197$3.59M
2020193,640$7.80M
2021249,405$9.95M
2022253,637$9.71M
2023245,570$9.67M
2024incomplete163,944$7.85M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 8.3% 38,689 36,162 $4.08M
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 8.2% 40,977 38,310 $4.00M
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 7.2% 41,798 38,951 $3.52M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 5.3% 19,962 18,836 $2.61M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 4.4% 17,522 16,466 $2.13M
J9271 Injection, pembrolizumab, 1 mg 3.3% 124 95 $1.62M
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 3.0% 18,648 6,292 $1.46M
96361 Intravenous infusion, hydration; each additional hour 2.9% 6,344 5,693 $1.43M
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 2.7% 5,041 1,753 $1.32M
80053 Comprehensive metabolic panel 2.3% 66,432 60,365 $1.11M
74177 Computed tomography, abdomen and pelvis; with contrast material 2.2% 4,840 4,754 $1.06M
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia 2.1% 794 754 $1.01M
473 more codes
90834 Psychotherapy session, about 45 minutes 1.9% 6,701 $920K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.8% 4,981 $885K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 1.8% 34,575 $858K
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.5% 6,161 $723K
70450 Computed tomography, head or brain; without contrast material 1.4% 2,994 $690K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.4% 3,459 $676K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 1.4% 1,910 $668K
99285 Emergency room visit (most serious) 1.3% 5,682 $655K
90839 1.2% 3,941 $569K
93975 1.0% 2,223 $511K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour 1.0% 2,481 $511K
99204 Doctor's office visit, new patient (more involved) <1% 3,749 $489K
99203 Doctor's office visit, new patient (routine) <1% 3,742 $453K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 3,463 $416K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 1,589 $378K
99244 Office or other outpatient consultation, moderate to high complexity <1% 2,880 $362K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV <1% 7,208 $332K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 9,982 $325K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 3,124 $314K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 12,007 $260K
90853 Group psychotherapy (other than of a multiple-family group) <1% 4,171 $255K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 12,018 $250K
96415 <1% 462 $249K
80048 Basic metabolic panel (calcium, ionized) <1% 13,672 $248K
84443 Thyroid stimulating hormone (TSH) <1% 29,415 $240K
90832 Psychotherapy session, about 30 minutes <1% 2,080 $223K
36415 Collection of venous blood by venipuncture <1% 50,410 $218K
97161 <1% 2,304 $217K
71275 Computed tomographic angiography, chest, with contrast material <1% 847 $214K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 6,608 $199K
99215 Doctor's office visit, returning patient (complex) <1% 1,580 $194K
73721 Magnetic resonance imaging, any joint of lower extremity; without contrast material <1% 747 $181K
42820 Tonsillectomy and adenoidectomy; younger than age 12 <1% 127 $180K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 3,467 $177K
77067 Screening mammography, bilateral, including computer-aided detection <1% 2,920 $175K
80061 Lipid panel <1% 24,805 $173K
83036 Hemoglobin; glycosylated (A1C) <1% 18,578 $169K
20610 <1% 671 $162K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 21,057 $153K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 4,261 $153K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 445 $144K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 3,885 $141K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 4,739 $141K
97162 <1% 1,124 $139K
93017 <1% 997 $138K
99396 Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years <1% 1,065 $135K
J2426 Injection, paliperidone palmitate extended release (invega sustenna), 1 mg <1% 74 $135K
87801 Infectious agent detection by nucleic acid; amplified probe, multiple organisms <1% 2,863 $134K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 54,714 $130K
70551 Magnetic resonance imaging, brain; without contrast material <1% 371 $122K
84439 <1% 12,801 $121K
99243 <1% 993 $120K
86850 <1% 4,316 $119K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 2,356 $119K
G0378 Hospital observation service, per hour <1% 1,539 $116K
92567 <1% 1,799 $115K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 702 $110K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 3,481 $110K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years <1% 850 $109K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 5,958 $106K
92557 <1% 1,859 $105K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 4,119 $103K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) <1% 870 $103K
82607 <1% 8,442 $103K
93971 <1% 1,726 $101K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 7,413 $100K
12001 <1% 256 $99K
87086 Culture, bacterial; quantitative colony count, urine <1% 13,477 $98K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 721 $93K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 1,238 $91K
90791 Psychiatric diagnostic evaluation <1% 516 $87K
93226 <1% 542 $86K
85027 <1% 22,227 $83K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 2,836 $83K
87636 Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B <1% 986 $81K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 202 $81K
76775 <1% 1,765 $79K
86618 <1% 3,782 $75K
99232 Hospital visit by a doctor, follow-up day <1% 1,131 $75K
82728 <1% 6,320 $74K
86901 <1% 4,615 $73K
93970 <1% 209 $72K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) <1% 589 $72K
92592 <1% 967 $70K
92593 <1% 821 $68K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 1,826 $67K
99408 <1% 1,602 $65K
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) <1% 91 $64K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 1,991 $64K
86780 <1% 4,977 $64K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 2,324 $62K
90847 Family psychotherapy with the patient present, 50 minutes <1% 311 $61K
87563 <1% 2,489 $59K
86900 <1% 4,617 $59K
87077 <1% 6,685 $58K
47562 <1% 24 $58K
86803 <1% 5,613 $57K
84153 <1% 3,118 $55K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 3,589 $54K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder <1% 471 $49K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 2,101 $49K
97166 <1% 401 $46K
90837 Psychotherapy session, about an hour <1% 338 $44K
83970 <1% 1,072 $44K
84702 <1% 4,400 $44K
99233 Hospital visit by a doctor, follow-up day (complex) <1% 448 $43K
84403 <1% 1,647 $43K
82746 <1% 3,619 $41K
71250 <1% 448 $41K
73221 <1% 174 $41K
93225 <1% 270 $40K
99442 <1% 1,032 $39K
69210 <1% 795 $38K
58661 <1% 24 $38K
76830 Ultrasound, transvaginal <1% 1,671 $37K
83880 <1% 1,123 $36K
45385 Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) <1% 55 $36K
31231 <1% 278 $36K
83655 <1% 2,477 $35K
99406 <1% 1,134 $34K
71271 <1% 1,103 $34K
99239 Hospital discharge day management, more than 30 minutes <1% 365 $34K
87522 Neg quan hep c or qual rna <1% 690 $33K
77065 Tomosynthesis, mammo <1% 467 $33K
90715 <1% 1,167 $33K
86762 <1% 2,075 $32K
99173 <1% 612 $31K
90686 <1% 1,124 $31K
30140 <1% 14 $31K
94060 <1% 201 $30K
88304 <1% 1,264 $30K
76536 <1% 1,364 $30K
90846 Family psychotherapy without the patient present, 50 minutes <1% 275 $29K
87340 <1% 2,647 $28K
85610 <1% 7,016 $28K
86140 <1% 7,852 $28K
83540 <1% 6,043 $28K
S5161 Emergency response system; service fee, per month (excludes installation and testing) <1% 818 $27K
70486 <1% 449 $27K
86617 <1% 1,021 $27K
83001 <1% 1,306 $26K
76642 <1% 1,415 $26K
86769 <1% 726 $26K
72125 Computed tomography, cervical spine; without contrast material <1% 1,006 $26K
99231 Subsequent hospital care, per day, straightforward or low complexity <1% 918 $26K
84146 <1% 1,362 $25K
77063 Screening digital breast tomosynthesis, bilateral <1% 2,519 $25K
88342 <1% 508 $25K
71046 Radiologic examination, chest; 2 views <1% 5,474 $25K
83735 <1% 11,460 $24K
82784 <1% 1,773 $24K
84402 <1% 949 $24K
97113 <1% 242 $24K
87186 <1% 3,807 $22K
86787 <1% 1,836 $22K
92551 <1% 325 $22K
82670 <1% 746 $21K
88307 <1% 281 $21K
83550 <1% 4,868 $20K
J1756 Injection, iron sucrose, 1 mg <1% 337 $20K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 1,956 $20K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 514 $20K
87653 <1% 798 $19K
99245 <1% 137 $18K
82043 <1% 3,425 $17K
86038 <1% 3,100 $17K
83002 <1% 906 $16K
86480 <1% 294 $16K
87468 <1% 622 $16K
99223 Prolong inpt eval add15 m <1% 96 $16K
85651 <1% 7,428 $16K
81001 <1% 9,699 $16K
87529 <1% 418 $15K
86235 <1% 741 $15K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 18,802 $15K
84481 <1% 1,503 $14K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 817 $14K
86376 <1% 851 $14K
12002 <1% 37 $14K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress <1% 24 $13K
85007 <1% 5,428 $13K
92550 <1% 163 $13K
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) <1% 103 $13K
82570 <1% 2,568 $13K
96367 <1% 159 $13K
76641 <1% 415 $13K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 113 $13K
92587 <1% 324 $12K
80076 <1% 1,116 $12K
99443 <1% 353 $12K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 2,368 $12K
87484 <1% 612 $12K
77080 <1% 197 $11K
87070 <1% 1,855 $11K
86665 <1% 358 $11K
77066 Tomosynthesis, mammo <1% 183 $11K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 11,032 $11K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 82 $11K
81025 <1% 3,387 $11K
99205 Prolong outpt/office vis <1% 85 $11K
90792 Psychiatric diagnostic evaluation with medical services <1% 62 $10K
77061 <1% 174 $10K
12011 <1% 28 $10K
87469 <1% 514 $10K
93298 <1% 444 $10K
99291 Critical care, evaluation and management of the critically ill patient, first 30-74 minutes <1% 58 $9K
77336 <1% 31 $9K
86430 <1% 1,946 $9K
83690 <1% 8,060 $9K
84550 <1% 2,203 $9K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 25 $9K
82550 <1% 2,336 $9K
86160 <1% 440 $9K
70496 <1% 39 $8K
51798 <1% 24 $8K
G0297 Low dose ct scan (ldct) for lung cancer screening <1% 189 $8K
J8597 Antiemetic drug, oral, not otherwise specified <1% 2,482 $8K
80050 General health panel <1% 332 $8K
73630 <1% 1,898 $8K
86706 <1% 854 $8K
73030 <1% 1,811 $8K
77062 <1% 104 $8K
73564 <1% 1,645 $8K
82803 <1% 293 $8K
76801 <1% 76 $7K
93297 <1% 428 $7K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 124 $7K
82950 <1% 1,381 $7K
94727 <1% 217 $7K
86696 <1% 442 $7K
86364 <1% 846 $7K
86800 <1% 490 $7K
84156 <1% 1,845 $7K
76000 <1% 84 $7K
70498 <1% 65 $7K
J2469 Injection, palonosetron hcl, 25 mcg <1% 1,295 $6K
74018 <1% 1,230 $6K
86666 <1% 349 $6K
83615 <1% 3,447 $6K
73610 <1% 1,864 $6K
90840 <1% 49 $6K
25600 <1% 12 $6K
99441 <1% 199 $6K
76870 <1% 373 $6K
90734 <1% 192 $5K
G2066 Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results <1% 85 $5K
84100 <1% 1,418 $5K
81003 <1% 7,072 $5K
82977 <1% 1,001 $5K
85730 <1% 1,575 $5K
73130 <1% 1,394 $5K
70491 <1% 25 $5K
73110 <1% 1,414 $5K
72110 <1% 261 $5K
86664 <1% 301 $4K
87177 <1% 291 $4K
82150 <1% 898 $4K
J0585 Injection, onabotulinumtoxina, 1 unit <1% 23 $4K
82947 <1% 563 $4K
72100 <1% 696 $4K
87046 <1% 346 $4K
73502 <1% 806 $4K
86663 <1% 303 $4K
73562 <1% 562 $4K
99238 Hospital discharge day management, 30 minutes or less <1% 85 $4K
M0245 Intravenous infusion, bamlanivimab and etesevimab, includes infusion and post administration monitoring <1% 15 $4K
94729 <1% 181 $3K
0012A <1% 134 $3K
J7120 Ringers lactate infusion, up to 1000 cc <1% 2,463 $3K
87641 <1% 94 $3K
85379 <1% 1,524 $3K
0002A <1% 80 $3K
90651 <1% 77 $3K
97022 <1% 135 $3K
76770 <1% 44 $3K
74246 <1% 13 $3K
87045 <1% 345 $3K
31575 <1% 61 $3K
87209 <1% 282 $3K
88341 <1% 112 $3K
98929 <1% 45 $2K
99222 Initial hospital care, per day, moderate complexity <1% 43 $2K
95886 <1% 26 $2K
82105 <1% 347 $2K
97597 <1% 44 $2K
M0222 Intravenous injection, bebtelovimab, includes injection and post administration monitoring <1% 12 $2K
87899 <1% 312 $2K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,138 $2K
93976 <1% 17 $2K
0011A <1% 136 $2K
A9575 Injection, gadoterate meglumine, 0.1 ml <1% 1,385 $2K
82948 <1% 4,662 $2K
93923 <1% 12 $2K
95816 <1% 13 $2K
73100 <1% 660 $2K
90619 <1% 47 $2K
84165 <1% 310 $2K
84460 <1% 480 $2K
84484 <1% 5,454 $2K
86765 <1% 132 $2K
93296 <1% 110 $2K
83516 <1% 229 $2K
80074 <1% 58 $2K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 364 $1K
0202U Oncology (prostate), multianalyte, gene expression profiling <1% 32 $1K
86225 <1% 281 $1K
84703 <1% 2,956 $1K
90656 <1% 93 $1K
0001A <1% 81 $1K
73140 <1% 770 $1K
86300 <1% 172 $1K
90882 <1% 85 $1K
83993 <1% 105 $1K
86694 <1% 207 $1K
85046 <1% 780 $1K
97116 <1% 26 $1K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 3,125 $1K
96375 Therapeutic injection; each additional sequential IV push <1% 9,509 $1K
71045 Radiologic examination, chest; single view <1% 5,458 $1K
73080 <1% 423 $1K
87040 <1% 1,290 $1K
84450 <1% 271 $1K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 13 $1K
86704 <1% 109 $1K
80178 <1% 114 $958.54
84480 <1% 122 $927.59
86735 <1% 87 $901.66
86147 <1% 54 $892.59
J3475 Injection, magnesium sulfate, per 500 mg <1% 1,229 $861.72
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 18 $845.90
88142 <1% 39 $834.05
83921 <1% 39 $746.95
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 8,486 $733.22
90677 <1% 14 $733.04
84425 <1% 52 $690.16
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 12 $670.26
90460 Immunization administration through 18 years of age via any route, first or only component <1% 1,156 $660.30
73090 <1% 143 $600.46
82533 <1% 40 $584.13
86255 <1% 107 $582.28
82565 <1% 113 $567.12
72050 <1% 42 $554.80
86215 <1% 102 $554.72
90710 <1% 25 $547.76
90670 <1% 26 $543.34
J0131 Injection, acetaminophen, not otherwise specified,10 mg <1% 1,987 $534.33
95806 <1% 79 $533.61
86756 <1% 185 $511.23
G0008 Administration of influenza virus vaccine <1% 77 $480.15
86708 <1% 50 $468.44
73590 <1% 166 $457.77
80164 <1% 40 $422.43
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 25 $413.81
72040 <1% 53 $410.67
96523 <1% 12 $402.06
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 8,177 $397.54
86334 <1% 28 $395.69
82747 <1% 51 $388.59
83010 <1% 40 $375.99
83605 <1% 1,674 $375.30
83525 <1% 30 $369.79
L3908 Wrist hand orthosis, wrist extension control cock-up, non molded, prefabricated, off-the-shelf <1% 339 $356.48
V5266 Battery for use in hearing device <1% 924 $338.39
87338 <1% 43 $331.46
82785 <1% 26 $329.13
82627 <1% 13 $293.40
80305 <1% 563 $286.54
J2704 Injection, propofol, 10 mg <1% 6,752 $284.14
84436 <1% 50 $262.20
V5014 Repair/modification of a hearing aid <1% 13 $260.22
84681 <1% 12 $249.71
J0690 Injection, cefazolin sodium, 500 mg <1% 1,634 $216.65
86231 <1% 29 $198.75
86753 <1% 91 $197.25
80348 <1% 87 $196.96
87808 <1% 49 $193.80
J2795 Injection, ropivacaine hydrochloride, 1 mg <1% 404 $179.85
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 941 $179.44
82247 <1% 41 $176.98
84155 <1% 68 $174.68
96376 <1% 1,278 $170.84
87328 <1% 12 $152.00
82103 <1% 12 $148.56
86308 <1% 71 $146.44
99484 <1% 2,101 $146.26
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 581 $145.40
J2270 Injection, morphine sulfate, up to 10 mg <1% 1,930 $140.88
82378 <1% 30 $139.11
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 1,349 $135.57
85732 <1% 25 $130.94
72072 <1% 12 $127.20
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 6,518 $126.32
88300 <1% 282 $118.40
73560 <1% 29 $117.19
76882 <1% 15 $112.96
J3010 Injection, fentanyl citrate, 0.1 mg <1% 6,791 $108.37
J1170 Injection, hydromorphone, up to 4 mg <1% 2,761 $101.36
85705 <1% 14 $96.60
85613 <1% 13 $94.10
86677 <1% 12 $89.20
86580 <1% 15 $82.50
86015 <1% 12 $78.02
L1820 Knee orthosis, elastic with condylar pads and joints, with or without patellar control, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise <1% 15 $76.88
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 2,262 $75.90
80324 <1% 14 $72.28
80353 <1% 14 $72.28
80359 <1% 14 $72.28
80358 <1% 14 $72.28
80346 <1% 14 $72.28
80365 <1% 14 $72.28
80354 <1% 14 $72.28
80361 <1% 14 $72.28
98968 <1% 324 $70.00
73600 <1% 15 $69.80
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 9,156 $69.31
85670 <1% 13 $68.23
J1650 Injection, enoxaparin sodium, 10 mg <1% 642 $68.08
A9500 Technetium tc-99m sestamibi, diagnostic, per study dose <1% 25 $66.00
85652 <1% 42 $65.86
82310 <1% 15 $65.61
71100 <1% 12 $65.00
90461 <1% 56 $60.00
80143 <1% 569 $58.29
84075 <1% 12 $54.90
80179 <1% 503 $52.70
86431 <1% 12 $50.22
98967 <1% 115 $50.00
82248 <1% 14 $49.33
83721 <1% 23 $47.83
84520 <1% 13 $41.52
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 2,122 $40.52
96417 <1% 234 $38.61
S0028 Injection, famotidine, 20 mg <1% 201 $36.03
73000 <1% 22 $33.00
J1790 Injection, droperidol, up to 5 mg <1% 982 $22.73
84132 <1% 13 $20.96
L4361 Walking boot, pneumatic and/or vacuum, with or without joints, with or without interface material, prefabricated, off-the-shelf <1% 166 $18.31
J2060 Injection, lorazepam, 2 mg <1% 1,609 $13.35
90472 Immunization administration, each additional vaccine (list separately) <1% 140 $11.00
J0689 Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg <1% 812 $10.70
J1030 Injection, methylprednisolone acetate, 40 mg <1% 118 $8.24
87071 <1% 25 $6.93
J1630 Injection, haloperidol, up to 5 mg <1% 237 $4.85
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 1,010 $4.01
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg <1% 615 $2.64
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 177 $1.65
C9113 Injection, pantoprazole sodium, per vial <1% 35 $1.05
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 32 $0.62
J8540 Dexamethasone, oral, 0.25 mg 0% 263 $0.00
A4648 Tissue marker, implantable, any type, each 0% 96 $0.00
C1769 Guide wire 0% 110 $0.00
J7999 Compounded drug, not otherwise classified 0% 65 $0.00
94760 0% 17 $0.00
J2175 Injection, meperidine hydrochloride, per 100 mg 0% 14 $0.00
V5264 Ear mold/insert, not disposable, any type 0% 42 $0.00
J2785 Injection, regadenoson, 0.1 mg 0% 12 $0.00
J9045 Injection, carboplatin, 50 mg 0% 24 $0.00
L4350 Ankle control orthosis, stirrup style, rigid, includes any type interface (e.g., pneumatic, gel), prefabricated, off-the-shelf 0% 54 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 41 $0.00
J3480 Injection, potassium chloride, per 2 meq 0% 36 $0.00
C1781 Mesh (implantable) 0% 13 $0.00
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 0% 48 $0.00
J7030 Infusion, normal saline solution , 1000 cc 0% 56 $0.00
88302 0% 42 $0.00
84145 0% 84 $0.00
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 0% 234 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 0% 12 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 26 $0.00
98966 0% 30 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 28 $0.00
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 0% 16 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 0% 25 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 46 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialAMADO, MITCHELL (CHIEF FINANCIAL OFFICER)